BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Arlington Capital Partners Announces Majority Investment in Grand River Aseptic Manufacturing

  Based in Grand Rapids, MI, GRAM is a leading contract, development and manufacturing organization (“CDMO”) focused on the development, manufacture and finishing of parenteral pharmaceuticals.

  November 14, 2017

   · 

  3 min read
• Drug Development

  Intra-Cellular Therapies Presents Data on Mechanism of Action of Lumateperone and ITI-214 at the 2017 Society for Neuroscience (SfN) Annual Meeting

  The event is being held in Washington DC, November 11-14.

  November 14, 2017

   · 

  4 min read
• BioMidwest

  MDA Awards $3.5M in New Research Grants

  The MDA today announced 13 new research and development grants totaling $3.5M to accelerate the development of treatments for muscular dystrophy, ALS and related life-threatening diseases.

  November 14, 2017

   · 

  7 min read
• Business

  Zynerba Pharmaceuticals Reports Third Quarter 2017 Financial Results and Operational Highlights

  As of September 30, 2017, cash and cash equivalents were $66.3 million, compared to $70.2 million as of June 30, 2017.

  November 14, 2017

   · 

  12 min read
• Business

  Veloxis Pharma Announces Financial Results for the First Nine Months of 2017

  Veloxis reported a net loss of tUSD 8,421 for the first nine months of 2017 compared to a net loss of tUSD 23,961 for the same period in 2016.

  November 14, 2017

   · 

  2 min read
• Business

  Breathtec Biomedical Unaware of Any Material Change

  The Company will continue to provide updates of any material changes if and when they occur.

  November 14, 2017

   · 

  2 min read
• Policy

  Tel Aviv District Court Ordered MediWound to Purchase Approximately $1.5M of PolyHeal Shares; MediWound Weighing an Appeal

  As previously disclosed, in 2010 MediWound entered into a series of agreements with Teva and PolyHeal to collaborate in the development, manufacturing and commercialization of PolyHeal’s wound product.

  November 14, 2017

   · 

  6 min read
• MedPharm Release: New Research Challenges Current Theories on Skin Penetration of Large Molecular Weight Drugs Offering Hope for the Discovery of New Treatments of Difficult-to-Treat Dermatological Diseases.

  New research, to be published in the Journal of Investigative Dermatology by UK and US scientists this month, challenges current theories on the permeation and penetration of large molecular weight molecules across and into human skin.

  November 14, 2017

   · 

  3 min read
• BioForest

  MolecularMD to Implement Promega’s Microsatellite Instability (MSI) Technology for Immuno-Oncology Applications

  MolecularMD announces that it has now become a Preferred Provider of Promega’s Microsatellite Instability (MSI) v1.2 Analysis System.

  November 14, 2017

   · 

  3 min read
• Business

  Former CenterWatch COO Joan Chambers Joins SCORR Marketing as Senior Strategic Advisor

  In her role, Chambers will capitalize on her extensive health science industry experience to provide strategic direction to SCORR’s global clients to help them meet their marketing goals.

  November 14, 2017

   · 

  1 min read